Name: Nanovesicular Transdermal Brain Targeting of Asenapine Maleate (en Inglés)
Price: 124.19 PEN
Availability: InStock
Author: Jyotsna, M.
ISBN: 9787363108130

portada Nanovesicular Transdermal Brain Targeting of Asenapine Maleate (en Inglés)

Formato

Libro Físico

Autor

M. Jyotsna

Editorial

Meem Publishers

Idioma

Inglés

N° páginas

144

Encuadernación

Tapa Blanda

Dimensiones

22.9 x 15.2 x 0.8 cm

Peso

0.20 kg.

ISBN13

9787363108130

Categorías

Psicología fisiológica y neuropsicología
Psicología cognitiva
Neurología y neurofisiología clínicas
Enfermedad y a problemas de salud concretos

Nanovesicular Transdermal Brain Targeting of Asenapine Maleate (en Inglés)

M. Jyotsna (Autor) · Meem Publishers · Tapa Blanda

Libro Nuevo

S/ 124,19

S/ 248,39

Ahorras: S/ 124,19

50% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Lunes 12 de Agosto y el Lunes 26 de Agosto.

Lo recibirás en cualquier lugar de Perú entre 2 y 5 días hábiles luego del envío.

Reseña del libro "Nanovesicular Transdermal Brain Targeting of Asenapine Maleate (en Inglés)"

The development and evaluation of a nanovesicular transdermal formulation of asenapine maleate, with the specific goal of targeting the brain. Asenapine maleate is a medication used for the treatment of certain neurological disorders, and the research aims to enhance its delivery to the brain through a novel transdermal approach.Nanovesicular transdermal formulations offer a promising means of drug delivery, as they can bypass the blood-brain barrier and directly target the brain tissues. This study involves the design and optimization of nanovesicular carriers to encapsulate asenapine maleate, enabling its efficient transport through the skin and into the brain.Researchers conduct thorough evaluations to assess the stability, drug release kinetics, and skin permeation capabilities of the nanovesicular formulation. Additionally, they investigate its safety and efficacy in animal models or potentially in clinical trials, exploring its potential for use as a non-invasive and patient-friendly alternative to conventional drug delivery methods.By successfully developing a nanovesicular transdermal formulation of asenapine maleate for brain targeting, this research could pave the way for significant advancements in treating neurological disorders. The findings have the potential to revolutionize drug delivery strategies, offering a more effective and convenient treatment approach for patients in need of brain-specific medications.